• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲状腺球蛋白表达、Ki-67 指数和淋巴结比率在甲状腺乳头状癌预后评估中的作用。

Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer.

机构信息

Department of Surgery, Sundsvall Hospital, 851 86, Sundsvall, Sweden.

Department of Molecular Medicine and Surgery, Karolinska Institutet, 171 77, Stockholm, SE, Sweden.

出版信息

Sci Rep. 2023 Jan 19;13(1):1070. doi: 10.1038/s41598-023-27684-3.

DOI:10.1038/s41598-023-27684-3
PMID:36658256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9852547/
Abstract

The clinical significance of thyroglobulin (Tg) expression in papillary thyroid cancer (PTC) has not been systematically explored in relation to the Ki-67 index, lymph node ratio (LNR), or other conventional prognostic predictors. In this retrospective study of 327 patients with PTC, we investigated the immunohistochemical expression of Tg in both primary tumors and their matching lymph node metastases in relation to the Ki-67 index, LNR, and clinical data. Tumoral Tg immunoreactivity was inversely correlated to the Ki-67 index and tumor recurrence. The Ki-67 index was higher in lymph node metastases (mean 4%) than in the primary tumors (mean 3%). Reduced Tg expression, estimated as 0-25% Tg positive tumor cells, was more common in lymph node metastases compared to primary tumors. In addition to advanced metastatic burden (defined as N1b stage and LNR ≥ 21%), low Tg expression (0-25% positive tumor cells) in lymph node metastases had a significant prognostic impact with shorter recurrence-free survival. These findings support the potential value of histopathological assessment of Tg expression and Ki-67 index in lymph node metastases as complementary predictors to anticipate the prognosis of PTC patients better.

摘要

在涉及 Ki-67 指数、淋巴结比值 (LNR) 或其他常规预后预测因素时,甲状腺球蛋白 (Tg) 在甲状腺乳头状癌 (PTC) 中的临床意义尚未得到系统探讨。在这项对 327 例 PTC 患者的回顾性研究中,我们研究了原发性肿瘤及其匹配的淋巴结转移中 Tg 的免疫组织化学表达与 Ki-67 指数、LNR 和临床数据的关系。肿瘤 Tg 免疫反应性与 Ki-67 指数和肿瘤复发呈负相关。淋巴结转移中的 Ki-67 指数(平均 4%)高于原发性肿瘤(平均 3%)。与原发性肿瘤相比,淋巴结转移中 Tg 表达减少(估计为 0-25% Tg 阳性肿瘤细胞)更为常见。除了晚期转移负担(定义为 N1b 期和 LNR≥21%)外,淋巴结转移中 Tg 表达(0-25%阳性肿瘤细胞)低与较短的无复发生存期有显著的预后影响。这些发现支持在淋巴结转移中评估 Tg 表达和 Ki-67 指数的组织病理学评估作为补充预测因素的潜在价值,以更好地预测 PTC 患者的预后。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def4/9852547/dbb1b77b3532/41598_2023_27684_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def4/9852547/280a217a7fec/41598_2023_27684_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def4/9852547/3594d8cc10d6/41598_2023_27684_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def4/9852547/7ccf992ee03d/41598_2023_27684_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def4/9852547/dbb1b77b3532/41598_2023_27684_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def4/9852547/280a217a7fec/41598_2023_27684_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def4/9852547/3594d8cc10d6/41598_2023_27684_Fig2a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def4/9852547/7ccf992ee03d/41598_2023_27684_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/def4/9852547/dbb1b77b3532/41598_2023_27684_Fig4_HTML.jpg

相似文献

1
Thyroglobulin expression, Ki-67 index, and lymph node ratio in the prognostic assessment of papillary thyroid cancer.甲状腺球蛋白表达、Ki-67 指数和淋巴结比率在甲状腺乳头状癌预后评估中的作用。
Sci Rep. 2023 Jan 19;13(1):1070. doi: 10.1038/s41598-023-27684-3.
2
The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer.甲状腺乳头状癌中淋巴结比值和 Ki-67 表达的临床意义。
World J Surg. 2021 Jul;45(7):2155-2164. doi: 10.1007/s00268-021-06070-y. Epub 2021 Apr 7.
3
Optimal value of lymph node ratio and metastatic lymph node size to predict risk of recurrence in pediatric thyroid cancer with lateral neck metastasis.颈侧区淋巴结转移的儿童甲状腺癌中预测复发风险的淋巴结比值和转移淋巴结大小的最佳值。
J Pediatr Surg. 2023 Mar;58(3):568-573. doi: 10.1016/j.jpedsurg.2022.07.010. Epub 2022 Jul 13.
4
Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.淋巴结比率可预测儿童乳头状甲状腺癌的复发情况。
J Pediatr Surg. 2019 Jan;54(1):129-132. doi: 10.1016/j.jpedsurg.2018.10.010. Epub 2018 Oct 5.
5
Lymph node ratio as a tool to stratify patients with N1b papillary thyroid cancer.淋巴结比率作为 N1b 期甲状腺乳头状癌患者分层的工具。
Langenbecks Arch Surg. 2023 Aug 16;408(1):315. doi: 10.1007/s00423-023-03033-w.
6
Analysis of factors associated with the prognosis of papillary thyroid cancer and the construction of a survival model.分析影响甲状腺乳头状癌预后的相关因素并构建生存模型。
Cancer Med. 2023 Apr;12(7):7868-7876. doi: 10.1002/cam4.5555. Epub 2022 Dec 22.
7
How Many Nodes to Take? Lymph Node Ratio Below 1/3 Reduces Papillary Thyroid Cancer Nodal Recurrence.需要切除多少个淋巴结?淋巴结比值小于 1/3 可降低甲状腺乳头状癌的淋巴结复发率。
Laryngoscope. 2022 Sep;132(9):1883-1887. doi: 10.1002/lary.30084. Epub 2022 Mar 1.
8
Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.消融术前刺激甲状腺球蛋白比淋巴结比率更能预测病理N1a期甲状腺乳头状癌的复发。
Int J Clin Oncol. 2016 Oct;21(5):862-868. doi: 10.1007/s10147-016-0956-2. Epub 2016 Feb 2.
9
Lymph node ratio independently associated with postoperative thyroglobulin levels in papillary thyroid cancer.淋巴结比率与甲状腺乳头状癌术后甲状腺球蛋白水平独立相关。
Oral Oncol. 2023 Nov;146:106563. doi: 10.1016/j.oraloncology.2023.106563. Epub 2023 Sep 9.
10
Thyroglobulin Determination in Fine Needle Aspiration Biopsy Washout of Suspicious Lymph Nodes in Thyroid Carcinoma Follow up.甲状腺癌随访中可疑淋巴结细针穿刺活检洗脱液中甲状腺球蛋白的测定
Endocr Metab Immune Disord Drug Targets. 2017;17(3):213-218. doi: 10.2174/1871530317666170531092501.

引用本文的文献

1
Gene Expression Analysis of Papillary Thyroid Carcinoma With Lymph Node Metastasis and Radioiodine Refractivity.伴有淋巴结转移和放射性碘难治性的乳头状甲状腺癌的基因表达分析
Cureus. 2025 Jun 29;17(6):e87001. doi: 10.7759/cureus.87001. eCollection 2025 Jun.
2
BRAF V600E and TERT promoter mutations and their impact on recurrent papillary thyroid carcinoma progression.BRAF V600E和端粒酶逆转录酶(TERT)启动子突变及其对复发性乳头状甲状腺癌进展的影响。
Endocr Connect. 2025 Jul 30;14(7). doi: 10.1530/EC-25-0116. Print 2025 Jul 1.
3
Digital spatial profiling identifies phospho-JNK as a biomarker for early risk stratification of aggressive prostate cancer.

本文引用的文献

1
Introduction and expression of PIK3CA in a papillary thyroid cancer BRAF cell line leads to a dedifferentiated aggressive phenotype.PIK3CA 在甲状腺癌 BRAF 细胞系中的引入和表达导致去分化的侵袭性表型。
J Otolaryngol Head Neck Surg. 2022 Feb 22;51(1):7. doi: 10.1186/s40463-022-00558-w.
2
Immunohistochemically detectable thyroglobulin expression in extrathyroidal cancer is 100% specific for thyroidal tumor origin.免疫组化可检测到的甲状腺外癌组织中的甲状腺球蛋白表达对甲状腺肿瘤起源具有100%的特异性。
Ann Diagn Pathol. 2021 Oct;54:151793. doi: 10.1016/j.anndiagpath.2021.151793. Epub 2021 Jul 15.
3
Pre-Therapeutic Measurements of Iodine Avidity in Papillary and Poorly Differentiated Thyroid Cancer Reveal Associations with Thyroglobulin Expression, Histological Variants and Ki-67 Index.
数字空间分析确定磷酸化JNK为侵袭性前列腺癌早期风险分层的生物标志物。
Front Oncol. 2025 Jun 5;15:1572299. doi: 10.3389/fonc.2025.1572299. eCollection 2025.
4
Prognostic value of lactate dehydrogenase to albumin ratio in first-line chemoimmunotherapy for locally advanced or metastatic non-small cell lung cancer.乳酸脱氢酶与白蛋白比值在局部晚期或转移性非小细胞肺癌一线化疗免疫治疗中的预后价值
Transl Cancer Res. 2025 May 30;14(5):2956-2965. doi: 10.21037/tcr-2024-2577. Epub 2025 May 13.
5
Prognostic value of MIB-1 index in meningioma: a retrospective cohort study to establish an optimal cutoff for recurrence and survival.MIB-1指数在脑膜瘤中的预后价值:一项回顾性队列研究以确定复发和生存的最佳临界值
J Neurooncol. 2025 May 12. doi: 10.1007/s11060-025-05057-2.
6
KI-67 as a predictive indicator of papillary thyroid cancer in Iraqi patients.KI-67作为伊拉克患者甲状腺乳头状癌的预测指标。
Probl Endokrinol (Mosk). 2024 Mar 7;70(6):62-66. doi: 10.14341/probl13410.
7
Environmental Exposure to Bisphenol A Enhances Invasiveness in Papillary Thyroid Cancer.环境暴露于双酚A会增强甲状腺乳头状癌的侵袭性。
Int J Mol Sci. 2025 Jan 19;26(2):814. doi: 10.3390/ijms26020814.
8
Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and post-operative findings.基于术前、术中和术后发现的乳头状和滤泡状癌的预后因素。
Eur Thyroid J. 2024 Oct 4;13(5). doi: 10.1530/ETJ-24-0196. Print 2024 Oct 1.
9
Clinical and Paraclinical Considerations Regarding ki67's Role in the Management of Differentiated Thyroid Carcinoma-A Literature Review.临床和辅助检查考虑因素:Ki67 在分化型甲状腺癌管理中的作用——文献综述。
Medicina (Kaunas). 2024 May 7;60(5):769. doi: 10.3390/medicina60050769.
甲状腺乳头状癌和低分化甲状腺癌碘摄取的治疗前测量揭示了与甲状腺球蛋白表达、组织学亚型及Ki-67指数的相关性。
Cancers (Basel). 2021 Jul 20;13(14):3627. doi: 10.3390/cancers13143627.
4
The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer.甲状腺乳头状癌中淋巴结比值和 Ki-67 表达的临床意义。
World J Surg. 2021 Jul;45(7):2155-2164. doi: 10.1007/s00268-021-06070-y. Epub 2021 Apr 7.
5
How should molecular findings be integrated in the classification for lung cancer?分子学发现应如何整合到肺癌的分类中?
Transl Lung Cancer Res. 2020 Oct;9(5):2245-2254. doi: 10.21037/tlcr-20-153.
6
Histopathology and immunohistochemistry as prognostic factors for poorly differentiated thyroid cancer in a series of Polish patients.波兰患者系列中低分化甲状腺癌的组织病理学和免疫组织化学预后因素。
PLoS One. 2020 Feb 24;15(2):e0229264. doi: 10.1371/journal.pone.0229264. eCollection 2020.
7
Immunocytochemical characteristics of thyrocytes in radioiodine refractory metastases of papillary thyroid cancer.甲状腺乳头状癌放射性碘难治性转移灶中甲状腺细胞的免疫细胞化学特征
Exp Oncol. 2019 Dec;41(4):342-345. doi: 10.32471/exp-oncology.2312-8852.vol-41-no-4.13705.
8
Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer.配对的原发性和转移性甲状腺乳头状癌的全外显子组测序。
Thyroid. 2020 Jan;30(1):42-56. doi: 10.1089/thy.2019.0052. Epub 2019 Dec 4.
9
Immunohistochemical characteristics of brain metastases and corresponding primary lung cancer.脑转移瘤及相应原发性肺癌的免疫组化特征
J BUON. 2019 Jul-Aug;24(4):1626-1637.
10
Mouse Model of Thyroid Cancer Progression and Dedifferentiation Driven by STRN-ALK Expression and Loss of p53: Evidence for the Existence of Two Types of Poorly Differentiated Carcinoma.由 STRN-ALK 表达和 p53 缺失驱动的甲状腺癌进展和去分化的小鼠模型:两种低分化癌存在的证据。
Thyroid. 2019 Oct;29(10):1425-1437. doi: 10.1089/thy.2019.0284. Epub 2019 Aug 16.